ArticleCureus2025
Empowering the Patient With Chronic Obstructive Pulmonary Disease: Optimizing Inhalation Technique.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung disease characterized by chronic respiratory symptoms. Validated tools such as the modified Medical Research Council (mMRC) and COPD Assessment Test (CAT) questionnaires are commonly used to assess these symptoms. In Portugal, it is estimated that COPD affects approximately 14.2% of individuals aged 40 and over. Compliance with inhalation therapy remains a significant challenge. Inconsistent and incorrect use of inhalers contributes to suboptimal disease control and deteriorates the patients' quality of life. Regular evaluations provide a valuable opportunity to monitor symptom progression, assess therapeutic compliance, and understand patients' beliefs and expectations about their treatment. Objective The primary aim of this study was to enhance the correct use of inhalers at the Porto Centro Family Health Unit by at least 20% of the COPD patients included. The secondary goal was to evaluate how inhaler therapy compliance and proper technique impact the symptomatic control of COPD, as measured by the mMRC and CAT scales. Methods A prospective observational cohort study was developed, with an intervention component. Data were gathered through random sampling of patients diagnosed with COPD. Participants were invited for an initial evaluation, where they were educated about the disease, instructed on the correct inhalation technique, and assessed for both symptom severity and inhaler technique. They were then re-assessed at a follow-up visit. Descriptive and analytical statistical methods were applied to compare and interpret the results. This study was approved by the Ethics Committee of Local Health Unit São João. Results A total of 60 patients were randomly selected for participation. After applying exclusion criteria, refusal to participate, and missed appointments, 19 participants completed the study. Approximately two-thirds of the patients initially failed at least one step of the inhalation technique. Following the intervention, 79% of the patients were able to correctly perform all steps, reflecting a 47% improvement. Symptom assessment using the CAT questionnaire showed scores ranging from 8 to 21 (median = 8) at the first visit, which improved to a range of 0 to 21 (median = 4) at the follow-up visit. In terms of mMRC scores, only one patient showed a worsening of dyspnea classification, three patients improved, and the remaining patients had stable classifications. Discussion Inhalation therapy is crucial for effective COPD management. Following the intervention, a 47% improvement in inhaler technique was observed, which could lead to better disease control, fewer hospital admissions, and an enhanced quality of life. Although there are limitations such as the small sample size, the study demonstrated symptom improvement between the first and second visits, potentially indicating improved disease management. Conclusions This study highlights the impact that a focused intervention in managing COPD can have on improving patient outcomes and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.